Results for tag: "Premenstrual Syndrome Drug"

The Premenstrual Syndrome (PMS) Drug market is a subset of the Sexual and Reproductive Health Drugs market. PMS drugs are used to treat the physical and psychological symptoms associated with premenstrual syndrome, such as mood swings, irritability, bloating, and breast tenderness. These drugs are typically taken orally, and may include hormonal contraceptives, non-steroidal anti-inflammatory drugs, and selective serotonin reuptake inhibitors. The PMS Drug market is driven by the increasing prevalence of premenstrual syndrome, as well as the growing awareness of the condition and its associated symptoms. Additionally, the availability of generic drugs and the increasing demand for over-the-counter medications are expected to drive the market. Some companies in the PMS Drug market include Bayer AG, Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Novartis AG, and Eli Lilly and Company. Show Less Read more